Medical Xpress·4 min read·hard
Stockpiled Ebola vaccines trigger antibody response against Bundibugyo virus in lab tests
S
Sanjukta Mondal
✦AI Summary
Lab tests indicate that vaccines originally developed for the Zaire ebolavirus can trigger an immune response against the Bundibugyo virus. This finding suggests a potential pathway for protecting populations against the ongoing outbreak in Central Africa.
edited by Sadie Harley , reviewed by Robert Egan
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in